1. Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi® and Epclusa®. Issue 16 (15th August 2019) Authors: Link, John O.; Taylor, James G.; Trejo-Martin, Alejandra; Kato, Darryl; Katana, Ashley A.; Krygowski, Evan S.; Yang, Zheng-Yu; Zipfel, Sheila; Cottell, Jeromy J.; Bacon, Elizabeth M.; Tran, Chinh V.; Yang, Cheng Y.; Wang, Yujin; Wang, Kelly W.; Zhao, Guangyu; Cheng, Guofeng; Tian, Yang; Gong, Ruo... Journal: Bioorganic & medicinal chemistry letters Issue: Volume 29:Issue 16(2019) Page Start: 2415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗